The entire Giuseppe Meazza Stadium was holding their breath as Cristiano Ronaldo was about to score the penalty that would make Real Madrid win the Champions League final.
Rio Ferdinand Reaction to Cristiano Ronaldo goal that got Real Madrid winning another Champions League final.
In a post-game interview, Cristiano Ronaldo said he asked his coach Zinédine Zidane to score the last penalty because that would be the winning goal. That's what happened. Atletico Madrid failed to score their fourth penalty shootout, leaving Cristiano Ronaldo with the responsibility of taking the trophy home. He scored.
In the stands watching was the English former professional footballer Rio Ferdinand, which was Ronaldo's former Manchester United teammate. Mr. Ferdinand couldn't hide his excitation and shouted "he deserves that!" just after the player scored the winning goal.
Mr. Ferdinand uploaded the video of him watching Cristiano Ronaldo’s penalty to Instagram and said:
"When you are as committed to working as hard as Cristiano does to do what he does year in year out at the highest level, you deserve some fortune/luck. He didn't have his finest 120mins in a Real Madrid shirt, but he got the fortune to be the man with the opportunity to score the winning penalty. I was always told as a kid - you work hard, you get lucky!
Lucky is to get the opportunity to take the winning penalty, after that it's down to nerve, technique & composure. Game won!"
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
